Canadian guideline for Parkinson disease

Authors: David A. Grimes, Megan J. Fitzpatrick, Joyce Gordon, Janis M. Miyasaki, Edward A. Fon, Michael G. Schlossmacher, Oksana Suchowersky, Alexander Rajput, Anne Lafontaine, Tiago Mestre, Silke Appel‐Cresswell, Suneil K. Kalia, Kerrie Schoffer, Mateusz Zurowski, Ronald B. Postuma, Sean Udow, Susan H. Fox, Pauline Barbeau, Brian Hutton - Canadian Medical Association Journal 2019 cited by 167

[See related article at [www.cmaj.ca/lookup/doi/10.1503/cmaj.191089][2]][2] KEY POINTS Parkinson disease is chronic and progressive in nature, decreasing the quality of life for both patients with the disease and their caregivers and placing an onerous economic burden on society.[1][2] The first